BioPharma EHS Podcast Episode #6

I2P2 and GHS - important OSHA regulatory issues for 2011. In this episode of the BioPharma EHS podcast, Dean M. Calhoun, CIH - President and CEO of Affygility Solutions discusses two of OSHA's regulatory issues for the calendar year 2011 that will effect the biotechnology and pharmaceutical industry. The first issue is OSHA's Injury and Illness Prevention Program, and the second is the Global Harmonization System for Classifying and Labeling Chemicals. In you have a question regarding an environmental, health and safety issue please call our listener voicemail feedback line at 206-984-3214 or contact us online.

Episode metadata supplied by the publisher feed · Published Jan 10, 2011

Embed this episode

Attribution link and audio player

Ready to play

BioPharma EHS Podcast Episode #6

0:00 20:25

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

BioCentury This Week BioCentury BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem. Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere Jesús E. Moreno Hosted by Jesús E. Moreno (Business Development Director, bioaccess®), Global Trial Accelerators™ is a clinical trials podcast for life-sciences founders and innovators in MedTech, Biotech/Biopharma, and Radiopharma, focused on first-in-human (FIH) and early feasibility studies. The show is produced by bioaccess® and was founded by Co-Founder & CEO Julio G. Martinez-Clark. bioaccess® is a CRO purpose-built for first-in-human (FIH) trials, serving MedTech, Biopharma, and Radiopharma startups. This podcast delivers strategies, regulatory insights, and founder stories to get your technology into humans faster and affordably, with data designed to support FDA and EMA submissions. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and founders who have compressed timelines, reduced costs, and generated the clinical evidence investors demand by drawing on on-demand clinical research capability across the Americas. What You Business Of Biotech Ben Comer The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect. BioBoss John Simboli BioBoss is a podcast about leadership in the biopharma community. Hear directly from the founders and CEOs of today's most innovative companies. Listen in as Wyant Simboli Principal and branding veteran John Simboli poses the questions "What drives you? How do you create change? Why should people care?" to biopharma leaders and hear insights on this rapidly developing field.

Frequently Asked Questions

How long is this episode of Biopharma EHS?

This episode is 20 minutes long.

When was this Biopharma EHS episode published?

This episode was published on January 10, 2011.

Can I download this Biopharma EHS episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!